RDX 020
Alternative Names: RDX-020Latest Information Update: 14 Mar 2024
At a glance
- Originator Ardelyx
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Metabolic disorders